Adverse Effects of Modest Sleep Restriction on Sleepiness, Performance, and Inflammatory Cytokines

Alexandros N. Vgontzas, E. Zoumakis, E. O. Bixler, H. M. Lin, H. Follett, A. Kales, G. P. Chrousos

Research output: Contribution to journalArticle

617 Citations (Scopus)

Abstract

Total sleep restriction in humans is associated with increased daytime sleepiness, decreased performance, and hormonal/metabolic disturbances. The effects of mild chronic sleep restriction that mimic real life are not known. To assess the effects of modest sleep restriction from 8 to 6 h/night for I wk, 25 young, healthy, normal sleepers (12 men and 13 women) were studied for 12 consecutive nights in the sleep laboratory. After I wk of sleep restriction, although subjects' nighttime sleep was deeper, subjects were significantly sleepier (multiple sleep latency test) and performed worse in four primary variables of psychomotor vigilance test (both P < 0.01). Furthermore, 24-h secretion of IL-6 was increased by 0.8 ± 0.3 pghnl (P < 0.05) in both sexes, whereas TNFα was increased only in men. Also, the peak cortisol secretion was lower after sleep restriction than at baseline, and this difference was stronger in men (55.18 ± 24.83 nmol/liter; P < 0.05) than in women (35.87 ± 24.83 nmol/liter; P < 0.16). We conclude that in young men and women, modest sleep loss is associated with significant sleepiness, impairment of psychomotor performance, and increased secretion of proinflammatory cytokines. Given the potential association of these behavioral and physical alterations with health, well-being, and public safety, the idea that sleep or parts of it are optional should be regarded with caution.

Original languageEnglish (US)
Pages (from-to)2119-2126
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number5
DOIs
StatePublished - May 1 2004

Fingerprint

Sleep
Cytokines
Psychomotor Performance
Hydrocortisone
Interleukin-6
Health
Safety

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Vgontzas, Alexandros N. ; Zoumakis, E. ; Bixler, E. O. ; Lin, H. M. ; Follett, H. ; Kales, A. ; Chrousos, G. P. / Adverse Effects of Modest Sleep Restriction on Sleepiness, Performance, and Inflammatory Cytokines. In: Journal of Clinical Endocrinology and Metabolism. 2004 ; Vol. 89, No. 5. pp. 2119-2126.
@article{4f98de4d2fc24ecb996a8924cf1173c1,
title = "Adverse Effects of Modest Sleep Restriction on Sleepiness, Performance, and Inflammatory Cytokines",
abstract = "Total sleep restriction in humans is associated with increased daytime sleepiness, decreased performance, and hormonal/metabolic disturbances. The effects of mild chronic sleep restriction that mimic real life are not known. To assess the effects of modest sleep restriction from 8 to 6 h/night for I wk, 25 young, healthy, normal sleepers (12 men and 13 women) were studied for 12 consecutive nights in the sleep laboratory. After I wk of sleep restriction, although subjects' nighttime sleep was deeper, subjects were significantly sleepier (multiple sleep latency test) and performed worse in four primary variables of psychomotor vigilance test (both P < 0.01). Furthermore, 24-h secretion of IL-6 was increased by 0.8 ± 0.3 pghnl (P < 0.05) in both sexes, whereas TNFα was increased only in men. Also, the peak cortisol secretion was lower after sleep restriction than at baseline, and this difference was stronger in men (55.18 ± 24.83 nmol/liter; P < 0.05) than in women (35.87 ± 24.83 nmol/liter; P < 0.16). We conclude that in young men and women, modest sleep loss is associated with significant sleepiness, impairment of psychomotor performance, and increased secretion of proinflammatory cytokines. Given the potential association of these behavioral and physical alterations with health, well-being, and public safety, the idea that sleep or parts of it are optional should be regarded with caution.",
author = "Vgontzas, {Alexandros N.} and E. Zoumakis and Bixler, {E. O.} and Lin, {H. M.} and H. Follett and A. Kales and Chrousos, {G. P.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1210/jc.2003-031562",
language = "English (US)",
volume = "89",
pages = "2119--2126",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

Adverse Effects of Modest Sleep Restriction on Sleepiness, Performance, and Inflammatory Cytokines. / Vgontzas, Alexandros N.; Zoumakis, E.; Bixler, E. O.; Lin, H. M.; Follett, H.; Kales, A.; Chrousos, G. P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 5, 01.05.2004, p. 2119-2126.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adverse Effects of Modest Sleep Restriction on Sleepiness, Performance, and Inflammatory Cytokines

AU - Vgontzas, Alexandros N.

AU - Zoumakis, E.

AU - Bixler, E. O.

AU - Lin, H. M.

AU - Follett, H.

AU - Kales, A.

AU - Chrousos, G. P.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Total sleep restriction in humans is associated with increased daytime sleepiness, decreased performance, and hormonal/metabolic disturbances. The effects of mild chronic sleep restriction that mimic real life are not known. To assess the effects of modest sleep restriction from 8 to 6 h/night for I wk, 25 young, healthy, normal sleepers (12 men and 13 women) were studied for 12 consecutive nights in the sleep laboratory. After I wk of sleep restriction, although subjects' nighttime sleep was deeper, subjects were significantly sleepier (multiple sleep latency test) and performed worse in four primary variables of psychomotor vigilance test (both P < 0.01). Furthermore, 24-h secretion of IL-6 was increased by 0.8 ± 0.3 pghnl (P < 0.05) in both sexes, whereas TNFα was increased only in men. Also, the peak cortisol secretion was lower after sleep restriction than at baseline, and this difference was stronger in men (55.18 ± 24.83 nmol/liter; P < 0.05) than in women (35.87 ± 24.83 nmol/liter; P < 0.16). We conclude that in young men and women, modest sleep loss is associated with significant sleepiness, impairment of psychomotor performance, and increased secretion of proinflammatory cytokines. Given the potential association of these behavioral and physical alterations with health, well-being, and public safety, the idea that sleep or parts of it are optional should be regarded with caution.

AB - Total sleep restriction in humans is associated with increased daytime sleepiness, decreased performance, and hormonal/metabolic disturbances. The effects of mild chronic sleep restriction that mimic real life are not known. To assess the effects of modest sleep restriction from 8 to 6 h/night for I wk, 25 young, healthy, normal sleepers (12 men and 13 women) were studied for 12 consecutive nights in the sleep laboratory. After I wk of sleep restriction, although subjects' nighttime sleep was deeper, subjects were significantly sleepier (multiple sleep latency test) and performed worse in four primary variables of psychomotor vigilance test (both P < 0.01). Furthermore, 24-h secretion of IL-6 was increased by 0.8 ± 0.3 pghnl (P < 0.05) in both sexes, whereas TNFα was increased only in men. Also, the peak cortisol secretion was lower after sleep restriction than at baseline, and this difference was stronger in men (55.18 ± 24.83 nmol/liter; P < 0.05) than in women (35.87 ± 24.83 nmol/liter; P < 0.16). We conclude that in young men and women, modest sleep loss is associated with significant sleepiness, impairment of psychomotor performance, and increased secretion of proinflammatory cytokines. Given the potential association of these behavioral and physical alterations with health, well-being, and public safety, the idea that sleep or parts of it are optional should be regarded with caution.

UR - http://www.scopus.com/inward/record.url?scp=2442516101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442516101&partnerID=8YFLogxK

U2 - 10.1210/jc.2003-031562

DO - 10.1210/jc.2003-031562

M3 - Article

C2 - 15126529

AN - SCOPUS:2442516101

VL - 89

SP - 2119

EP - 2126

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -